Biotel

Description

Biotel

Investor Profile

Biotel has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Series C (50%)
Series B (50%)

Country Focus

Israel (100%)

Industry Focus

Biotechnology
Pharmaceutical
Health Care
Therapeutics
Life Science

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biotel frequently co-invest with?

OrbiMed

North America, New York, United States, New York

Co-Investments: 1

Integra Holdings

Europe, Zurich, Switzerland, Wallisellen

Co-Investments: 1

Israel Biotech Fund

Asia, HaMerkaz, Israel, Rehovot

Co-Investments: 2

Migdal Insurance and Financial Holdings

Asia, HaMerkaz, Israel, Petah Tikwah

Co-Investments: 1

Arkin Bio Ventures

Asia, Tel Aviv, Israel, Herzliya

Co-Investments: 1

Cystic Fibrosis Foundation

North America, Maryland, United States, Bethesda

Co-Investments: 1

Phoenix Financial

Asia, Tel Aviv, Israel, Tel Aviv

Co-Investments: 1

Primera Capital

North America, California, United States, Oakland

Co-Investments: 1

What are some of recent deals done by Biotel?

Splisense

Jerusalem, Yerushalayim, Israel

Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.

BiotechnologyLife SciencePharmaceutical

Series BMay 13, 2021

Amount Raised: $28,500,000

BioSight

Carmiel, HaZafon, Israel

Biosight is a private Phase 2 clinical stage biotech company developing innovative therapeutics for hematological.

BiotechnologyHealth CarePharmaceuticalTherapeutics

Series CDec 2, 2020

Amount Raised: $27,000,000

Biotel

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Biotel frequently co-invest with?

What are some of recent deals done by Biotel?

Ready to Raise Capital?

Pages

Free tools